Mielóma multiplex: vizsgálatok itt: Kanada

In Kanada 48 Also abroad 703

48 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.

1. fázisNot yet taking people in Kanada
Study of Belantamab Mafodotin, Cevostamab, Pomalidomide for RRMM Patients (MAPLE)
Where
Edmonton, Halifax, London, Montreal, Ottawa, Toronto
Életkor
18 év to 100 év
People
108
Run by
Canadian Myeloma Research Group
See details and how to joinNCT07831122
1/2. fázisTaking people
A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma
Where
Calgary, Halifax, Toronto, Vancouver
Életkor
18 év and over
People
62 worldwide
Run by
Celgene
See details and how to joinNCT06988488 · EU 2025-522090-11-00
2. fázisTaking people
Study of Iberdomide, Bortezomib, Dexamethasone With Isatuximab Added on Demand for ND-NTE MM Patients
Where
Edmonton, Halifax, London, Montreal, St. John's, Toronto
Életkor
65 év and over
People
75
Run by
Canadian Myeloma Research Group
See details and how to joinNCT05272826
3. fázisTaking people
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
Where
Calgary, Edmonton, Halifax, Hamilton, Montreal, Saskatoon, Toronto
Életkor
18 év and over
People
893 worldwide
Run by
Pfizer
See details and how to joinNCT05020236 · EU 2023-509208-14-00
3. fázisTaking people
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
Where
Moncton, Montreal
Életkor
18 év and over
People
492 worldwide
Run by
Pfizer
See details and how to joinNCT06152575 · EU 2023-507871-23-00
3. fázisTaking people
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
Where
Calgary, Halifax, Montreal, Ottawa, Sherbrooke, Vancouver
Életkor
18 év and over
People
750 worldwide
Run by
AstraZeneca
See details and how to joinNCT07764978
3. fázisNot yet taking people in Kanada
A Study to Evaluate Adverse Events and Change in Disease Activity With Injected Etentamig Plus Oral Pomalidomide Versus Standard Therapies in Adults With Relapsed or Refractory Multiple Myeloma
Where
London, Montreal, Victoria
Életkor
18 év and over
People
520 worldwide
Run by
AbbVie
See details and how to joinNCT07728188 · EU 2026-525596-11-00
4. fázisTaking people
Immunoglobulins in Multiple Myeloma Patients Receiving a BCMA-Directed T Cell Engager
Where
Lévis, Québec
Életkor
18 év and over
People
80
Run by
CHU de Quebec-Universite Laval
See details and how to joinNCT07094048
1. fázisTaking people
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
Where
Calgary, Toronto
Életkor
18 év and over
People
187 worldwide
Run by
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
See details and how to joinNCT06121843
1/2. fázisTaking people
Selinexor and Backbone Treatments of Multiple Myeloma Patients
Where
Calgary, Edmonton, Halifax, Montreal, St. John's, Toronto, Vancouver, Winnipeg
Életkor
18 év and over
People
300 worldwide
Run by
Karyopharm Therapeutics Inc
See details and how to joinNCT02343042
4. fázisTaking people
Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)
Where
Calgary, Edmonton, Montreal
Életkor
18 év and over
People
80 worldwide
Run by
Pfizer
See details and how to joinNCT06057402 · EU 2023-505200-33-00
1. fázisTaking people
Study of the Safety and Usefulness of Liposomal Curcumin in Multiple Myeloma
Where
Toronto
Életkor
18 év and over
People
20
Run by
University Health Network, Toronto
See details and how to joinNCT07456605
1. fázisTaking people
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma
Where
Montreal, Toronto
Életkor
18 év and over
People
135 worldwide
Run by
AbbVie
See details and how to joinNCT06896916 · EU 2024-512146-41-00
No phaseTaking people
LIVInG With chrONic Cancer TrEatments (LONGEVITI) Study
Where
Edmonton
Életkor
18 év to 90 év
People
75
Run by
University of Alberta
See details and how to joinNCT05645510
3. fázisTaking people
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
Where
Saint John
Életkor
18 év and over
People
520 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT06679101 · EU 2024-516030-35-00
2. fázisTaking people
Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)
Where
Edmonton, Kelowna, Kingston, London, Montreal, Ottawa, Regina, Saskatoon, Toronto, Vancouver
Életkor
18 év and over
People
720
Run by
Canadian Cancer Trials Group
See details and how to joinNCT03297606
1. fázisTaking people
A Study to Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneously in Adult Participants With Relapsed/Refractory Myeloma
Where
Montreal, Sherbrooke, Vancouver
Életkor
18 év and over
People
87 worldwide
Run by
Sanofi
See details and how to joinNCT06630806
1/2. fázisTaking people
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Where
Calgary, Edmonton
Életkor
12 év and over
People
606 worldwide
Run by
Sumitomo Pharma America, Inc.
See details and how to joinNCT04988555
4. fázisTaking people
Plan Development for Giving Teclistamab in the Outpatient Setting
Where
Toronto
Életkor
18 év and over
People
15
Run by
University Health Network, Toronto
See details and how to joinNCT06251076
No phaseTaking people
Early Palliative Care for Patients With Multiple Myeloma and Aggressive Lymphoma
Where
Toronto
Életkor
18 év and over
People
144
Run by
University Health Network, Toronto
See details and how to joinNCT06485076
1/2. fázisTaking people
A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma
Where
Calgary, Edmonton, Toronto
Életkor
18 év and over
People
260 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT05372354 · EU 2023-509384-25-00
No phaseTaking people
Telo Genomics Technology to Detect & Profile Multiple Myeloma MRD
Where
Montreal
Életkor
18 év and over
People
70
Run by
Sir Mortimer B. Davis - Jewish General Hospital
See details and how to joinNCT05530096
No phaseNot yet taking people in Kanada
Development of an Intervention Integrating Procedures Combining Hypnosis and Virtual Reality in the Support of Patients with Hematological Cancer
Where
Montreal
Életkor
18 év and over
People
60
Run by
Ciusss de L'Est de l'Île de Montréal
See details and how to joinNCT06817759